Notably, tumor-infiltrating ILC1-like cells exhibited the most robust activation of both TGFβ pathways, with a markedly stronger activation of the non-canonical pathway relative to the other TINK subsets (Figure 3C). The gene discussed is TGFB1; the disease is neoplasm.